OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
October 17, 2012
Consider the time and expertise needed to maintain regulatory compliance and perform stability testing.
Consider these tools and strategies for optimizing the manufacturing process.
October 02, 2012
Today's pharmaceutical companies are striving to reduce costs and maximize efficiencies, and must make decisions on the best way to deploy their limited resources.
Working together affords many unseen opportunities for pharmaceutical innovation.
Measuring the size of the market for contract manufacturing services requires a careful hand.
September 02, 2012
The weak global economy adds to the challenges of bio/pharma companies and their suppliers.
August 02, 2012
Budgets for biopharmaceutical activities are gaining in select functional areas except outsourcing.
August 01, 2012
The author provides results and commentary on a survey analyzing outsourcing strategies, practices, challenges, and outcomes in the selection of a CRO.
An examination of the current and projected market for biosimilars, development costs for biosimilars compared with small-molecule generic drug, and partnerships in biosimilars.
The author discusses how a CDMO helps in gaining process understanding and in developing robust, high-quality products and processes.